We are live on ! Find out more
YMRC

Yorktown Management & Research Company Portfolio holdings

AUM $163M
1-Year Est. Return 68.53%
This Fund
S&P 500
This Quarter Est. Return
+9.59%
1 Year Est. Return
+68.53%
3 Year Est. Return
+222.75%
5 Year Est. Return
+299.09%
10 Year Est. Return
+935.04%
AUM
$148M
AUM Growth
+$15.1M
Cap. Flow
+$6.27M
Cap. Flow %
4.24%
Top 10 Hldgs %
16.2%
Holding
272
New
24
Increased
30
Reduced
11
Closed
25

Top Buys

Rank Stock Value
1
RMBS icon
Rambus
RMBS
+$681K
2
DAC icon
Danaos Corp
DAC
+$650K
3
NMRK icon
Newmark Group
NMRK
+$628K
4
KSS icon
Kohl's
KSS
+$623K
5
KLIC icon
Kulicke & Soffa
KLIC
+$612K

Top Sells

Rank Stock Value
1
JOBS
51job Inc
JOBS
+$563K
2
CAG icon
Conagra Brands
CAG
+$474K
3
CSGP icon
CoStar Group
CSGP
+$473K
4
INCY icon
Incyte
INCY
+$413K
5
EBS icon
Emergent Biosolutions
EBS
+$411K

Sector Composition

Rank Sector Weight
1 Technology 26.95%
2 Industrials 15.61%
3 Healthcare 15.03%
4 Financials 14.32%
5 Consumer Discretionary 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TROW icon
176
T. Rowe Price
TROW
$23.8B
$317K 0.21%
1,610
DXCM icon
177
DexCom
DXCM
$34.3B
$311K 0.21%
2,320
EXPE icon
178
Expedia Group
EXPE
$39.1B
$311K 0.21%
1,720
SFIX
179
Stitch Fix
SFIX
$474M
$310K 0.21%
16,400
+2,000
+14% +$57.3K
MRSH
180
Marsh
MRSH
$90.1B
$309K 0.21%
1,775
-315
-15% -$52.3K
CVS icon
181
CVS Health
CVS
$121B
$306K 0.21%
2,970
-320
-10% -$29.6K
CCI icon
182
Crown Castle
CCI
$31.5B
$303K 0.2%
1,450
REGN icon
183
Regeneron Pharmaceuticals
REGN
$82.2B
$303K 0.2%
480
ADM icon
184
Archer Daniels Midland
ADM
$38.4B
$302K 0.2%
4,465
SEDG icon
185
SolarEdge
SEDG
$1.97B
$302K 0.2%
1,075
SCHW
186
Charles Schwab
SCHW
$189B
$301K 0.2%
3,575
-650
-15% -$52.6K
EHC icon
187
Encompass Health
EHC
$12.3B
$300K 0.2%
5,782
LIN icon
188
Linde
LIN
$221B
$298K 0.2%
860
A icon
189
Agilent Technologies
A
$41.9B
$297K 0.2%
1,860
ACN icon
190
Accenture
ACN
$110B
$296K 0.2%
715
-245
-26% -$89.3K
TMO icon
191
Thermo Fisher Scientific
TMO
$223B
$296K 0.2%
443
-47
-10% -$29.3K
NEE icon
192
NextEra Energy
NEE
$179B
$294K 0.2%
3,150
PAGS icon
193
PagSeguro Digital
PAGS
$2.44B
$294K 0.2%
11,200
PEP icon
194
PepsiCo
PEP
$189B
$294K 0.2%
1,695
NDAQ icon
195
Nasdaq
NDAQ
$53.5B
$293K 0.2%
4,185
-1,425
-25% -$97.1K
CB icon
196
Chubb
CB
$132B
$290K 0.2%
1,500
GOOGL icon
197
Alphabet (Google) Class A
GOOGL
$4.2T
$290K 0.2%
2,000
-400
-17% -$57.6K
META icon
198
Meta Platforms (Facebook)
META
$1.47T
$289K 0.2%
860
DE icon
199
Deere & Co
DE
$167B
$288K 0.19%
840
SBSW icon
200
Sibanye-Stillwater
SBSW
$7.58B
$288K 0.19%
23,000

Similar funds

Yorktown Management & Research Company's Q4 2021 Portfolio in Review

As of Q4 2021, Yorktown Management & Research Company held 272 positions worth $148M, up 11% from $133M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Yorktown Management & Research Company deployed $6.27M of net new capital in Q4 2021, opening 24 new positions and adding to 30 existing holdings. Its largest new stake was Danaos Corp: 9,000 shares worth $672K.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Blackstone, an estimated $103K trimmed.

  • Yorktown Management & Research Company's largest Q4 2021 buy was Danaos Corp: 9,000 shares worth $672K.
  • Yorktown Management & Research Company added most to Rambus in Q4 2021, an estimated $681K increase.
  • Yorktown Management & Research Company's biggest Q4 2021 reduction was Blackstone, cutting an estimated $103K.
  • Yorktown Management & Research Company fully exited 51job Inc in Q4 2021, selling an estimated $563K.
  • Yorktown Management & Research Company's ten largest holdings make up 16% of its $148M portfolio in Q4 2021.
  • Yorktown Management & Research Company opened 24 new positions and closed 25 in Q4 2021.
  • Yorktown Management & Research Company's portfolio value rose 11% quarter-over-quarter to $148M.

Based on Yorktown Management & Research Company's 13F filing for Q4 2021, filed 9 Feb 2022.